Same-day total joint arthroplasty in the united states from 2016 to 2020: the impact of the medicare inpatient only list and the COVID-19 pandemic

MK Richardson, J Wier, KC Liu, CK Mayfield… - The Journal of …, 2024 - Elsevier
Background Same-day total hip arthroplasty (THA) and total knee arthroplasty (TKA)
continue to gain popularity in the United States. The present study sought to quantify recent …

Letter to the editor on “Intraoperative blood loss and haemoglobin drop in patients with developmental dysplasia of the hip in Jordan undergoing total hip arthroplasty”

X Liu, H Wu - International Orthopaedics, 2023 - Springer
Dear Editor, We read with great interest and appreciate the article titled “Intraoperative blood
loss and haemoglobin drop in patients with developmental dysplasia of the hip in Jordan …

Low Molecular Weight Heparin is Superior to Aspirin in the Prevention of Thromboembolic Disease, or is it? Response to an Editorial

IA Harris, VS Sidhu… - The Journal of …, 2023 - arthroplastyjournal.org
1. The editorial states that 'numerous recent randomized studies have shown that aspirin at
a dosage of 81 or 325 mg twice per day is an effective and safe modality for venous …

Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty—Reply

VS Sidhu, IA Harris - JAMA, 2023 - jamanetwork.com
To the Editor We have some comments about the CRISTAL study, 1 which investigated the
effect of aspirin vs enoxaparin on symptomatic venous thromboembolism (VTE) in patients …

[HTML][HTML] Riesgo de tromboembolismo venoso en la tromboprofilaxis entre aspirina y heparinas de bajo peso molecular tras una artroplastia total de cadera o …

JH Núñez, F Moreira, B Escudero-Cisneros… - Revista Española de …, 2023 - Elsevier
Introducción El objetivo de este estudio fue evaluar la eficacia de la aspirina vs. las
heparinas de bajo peso molecular (HBPM) para la profilaxis del tromboembolismo venoso …

Review of Article: CRISTAL Study Group. Effect of aspirin vs. enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty …

MO Whipple - 2022 - pubmed.ncbi.nlm.nih.gov
Review of Article: CRISTAL Study Group. Effect of aspirin vs. enoxaparin on symptomatic
venous thromboembolism in patients undergoing hip or knee arthroplasty: The CRISTAL …

Rectus Sheath Hematoma Following Subcutaneous Enoxaparin Application: A Case Report

NJ Graham, FAV Ledesma - International Journal of Medical Students, 2023 - ijms.pitt.edu
BACKGROUND: Thromboprophylaxis for prevention of venous thromboembolism has
significantly decreased morbidity and mortality for post-operative patients over the previous …

Verinder Singh Sidhu, MS

IA Harris - JAMA, 2022 - jamanetwork.com
1. Sidhu VS, Kelly TL, Pratt N, et al; CRISTAL Study Group. Effect of aspirin vs enoxaparin on
symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: the …

[PDF][PDF] Revista Española de Cirugía Ortopédica y Traumatología

JH Núnez, F Moreira, B Escudero-Cisneros… - 2023 - researchgate.net
Introducción: El objetivo de este estudio fue evaluar la eficacia de la aspirina vs. las
heparinas de bajo peso molecular (HBPM) para la profilaxis del tromboembolismo venoso …

[PDF][PDF] Response to Editorial on CRISTAL VTE trial

I Harris, V Sidhu, R Buchbinder - 2022 - cdn-links.lww.com
We thank Parvizi et al for their editorial and interest in our trial. However, we consider most
of their concerns to be unfounded. As we were not afforded the opportunity to review their …